Avicennia officinalis
Avicennia officinalis · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Avicennia officinalis is a versatile mangrove species recognized for its significant therapeutic potential in various medicinal applications. Research indicates that its methanolic leaf extract possesses diverse pharmacological activities, including anthelmintic, anti-HIV, antibacterial, and antiasthmatic properties. The plant is chemically rich in bioactive compounds such as flavonoids, glycosides, 2,4-bis(2-phenylpropan-2-yl)phenol, and 2-[4-[2-(dimethylamino)-2-oxo-1,1-diphenylethyl]phenyl]-2-phenylacetic acid. These constituents contribute to its effectiveness in addressing health conditions ranging from constipation and diuretic needs to the management of Alzheimer's disease. Consequently, this species serves as a vital natural resource for developing treatments for complex respiratory and neurological disorders.
- Synonyms
- Racka Ovata · Avicennia Obovata · 6 more
- Common names
- Not available
- Family
- Acanthaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Avicennia officinalis is a versatile mangrove species known by a diverse array of local and international names. In various regions, it is commonly referred to as Api-Api Daun-Lebar or Api-Api Ludat. It is also widely recognized under the descriptive titles of Indian Mangrove and Mangrovia indiana. Furthermore, the plant is sometimes identified by the name avicénia lekárska in certain contexts. This variety of nomenclature highlights the global presence and cultural significance of this important coastal plant.
Sources: Catalogue of Life (COL)
Synonyms
Avicennia officinalis is a taxonomically complex species that is frequently identified through various botanical synonyms. Within scientific literature, it has been referred to under the names Avicennia obovata and Avicennia oepata. The plant also encompasses several distinct forms, such as Avicennia officinalis f. flaviflora and Avicennia officinalis f. tomentosa. Additionally, researchers may classify specific variations under the name Avicennia officinalis var. acuminata. Understanding these diverse nomenclatures is essential for accurate identification and consistent study of the species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Avicennia officinalis belongs to the vast kingdom Plantae, representing a specialized group of living organisms. Within this biological hierarchy, the species is classified under the class Equisetopsida. It further descends through the order Lamiales, which helps define its structural characteristics. As a member of the genus Avicennia, it shares close evolutionary ties with its relatives. Finally, this plant is nested within the family Acanthaceae, completing its complex taxonomic identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Acanthaceae |
| Genus | Avicennia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Avicennia officinalis is a widespread species primarily distributed across the tropical regions of Asia. Its presence is deeply established throughout the Indian Subcontinent, spanning across India, Bangladesh, and Sri Lanka. The plant also extends its reach into the Indo-China region, specifically finding suitable habitats in Cambodia. Furthermore, its range includes the unique ecological landscapes of the Andaman Islands. This broad distribution highlights the species' ability to thrive in diverse coastal environments across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Avicennia officinalis is a self-supporting species that exhibits a distinct tree growth form. This robust plant is capable of reaching impressive dimensions in its natural habitat. Depending on environmental conditions, its height typically reaches a maximum of 18 meters. In optimal circumstances, however, the tree can grow even larger, reaching a maximum height of 25 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Avicennia officinalis is a medicinal plant recognized for its diverse range of traditional therapeutic applications. Research highlights its significant antiasthmatic properties, making it a valuable subject in ethnobotanical studies. Furthermore, investigations into the plant's bark have confirmed its potent diuretic activity, specifically through the increase of urinary output and electrolyte concentrations. The plant also demonstrates effective laxative potential, with certain fractions showing a dose-dependent ability to improve stool consistency. Ultimately, these biological activities suggest that the species could serve as a vital source of bioactive compounds for treating conditions like hypertension, edema, and constipation.
Compounds
Avicennia officinalis is a medicinal plant recognized for its diverse range of bioactive phytoconstituents. Research into its bark extracts has confirmed that the plant contains essential compounds such as flavonoids, saponins, and tannins. Furthermore, phytochemical analysis identifies the presence of glycosides within its most bioactive crude extracts. Specific solvent fractions also reveal the existence of steroids, contributing to the plant's complex chemical profile. These combined secondary metabolites suggest that the species may serve as a valuable source for developing new therapeutic agents.
Conditions
Avicennia officinalis demonstrates significant therapeutic potential, including the ability to treat Alzheimer's disease through its cholinesterase inhibitory activity. This medicinal plant is traditionally recognized for its anti-infective and antiasthmatic properties. Research into its bark extracts further suggests that it can be used to treat constipation due to its laxative effects. Additionally, the plant serves various biomedical applications, such as the green synthesis of nanoparticles. Through these diverse biological activities, the species offers a wide range of pharmaceutical possibilities.
Preparations
Avicennia officinalis is prepared as a methanolic leaf extract to investigate its potential therapeutic applications. This specific preparation is used to assess the plant's ability to inhibit cholinesterase enzymes in vitro. By incubating various concentrations of the extract, researchers can measure its impact on total and butyryl cholinesterase activities. The study demonstrates that this methanolic leaf extract achieves significant inhibitory activity at concentrations below 2 mg/mL. Such results suggest that the processed extract of Avicennia officinalis holds promise as an alternative medicinal treatment for Alzheimer's disease.